Literature DB >> 4151493

Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.

K Nakagawa, N Murakami, S Yoshizaki, M Tominaga, H Mori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4151493     DOI： 10.1021/jm00251a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Kushida; Y Horai; K Chiba; T Suganuma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.

Authors:  A Tarkiainen; K Saraste; T Seppälä; A Gordin; J Auvinen
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

3.  Evidence for tonic activation of prejunctional beta-adrenoceptors in guinea-pig pulmonary arteries by adrenaline derived from the adrenal medulla.

Authors:  Y Misu; M Kuwahara; H Amano; T Kubo
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

4.  Pharmacokinetics of carteolol in patients with impaired renal function.

Authors:  M Amemiya; K Tabei; H Furuya; Y Sakairi; Y Asano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.